Ader, PBlöck, M, Pietzsch, S & Wolffram, S 2001 Interaction of quercetin glucosides with the sodium/glucose cotransporter (SGLT1). Cancer Lett 162 175–180.
Adibi, SA 2003 Regulation of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am J Physiol Gastrointest Liver Physiol 285 G779–G788.
Andria, GCucchiara, S, De Vizia, B, De Ritis, G, Masaka, G & Aurichio, S 1980 Brush border and cytosol peptidase activities of human small intestine in normal subjects and celiac patients. Pediatr Res 14 812–818i.
Boyer, J, Brown, D & Liu, RH 2004 Uptake of quercetin and quercetin 3-glucoside from whole onion and apple peel extracts by Caco-2 cell monolayers. J Agric Food Chem 52 7172–7179.
Cermak, R, Landgraf, S & Wolffram, S 2004 Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br J Nutr 91 849–855.
Dahlqvist, A 1964 Method for assay of intestinal disaccharidases. Anal Biochem 7 18–25.
De Vries, JHM, Janssen, PL, Hollman, PCH, van Staveren, WA & Katan, MBCancer Lett 114. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets, 1997 114–141144.
Dillehay, DL, Webb, SK, Schmelz, EM & Merrill, AH Jr J Nutr. Dietary sphingomyelin inhibits 1, 2-dimethylhydrazine-induced colon cancer in CF1 mice, 1994 615–620.
Gee, JM, Du, Pont MS, Day, AJ, Plumb, GW, Williamson, G & Johnson, ITJ Nutr. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway, 2000 130 2765–2771.
Halliwell, B, Rafter, J & Jenner, J 2005 Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not?. Am J Clin Nutr 81 268–276.
Hopfer, U, Sigrist-Nelson, K, Perotto, J & Murer, H 1975 Intestinal sugar transport: studies with isolated plasma membranes. Ann N Y Acad Sci 264 414–427.
Katsura, T & Inui, K 2003 Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation. Drug Metab Pharmacokinet 18 1–15.
Lemonnier, LA, Dillehay, DL, Vespremi, MJ, Abrams, J, Brody, E & Schmelz, EM 2003 Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch Biochem Biophys 419 129–138.
Liu, RH 2004 Potential synergy of phytochemicals in cancer prevention:mechanism of action. J Nutr 134 3479–3485.
Merrill, AH Jr, Schmelz, EM, Wang, E, Dillehay, DL, Rice, LG, Meredith, F & Riley, RT 1997 Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets. J Nutr 127 830S–833S.
Moskaug, JO, Carlsen, H, Myhrstad, M & Blomhoff, R 2004 Molecular imaging of the biological effects of quercetin and quercetin rich foods. Mech Ageing Dev 125 315–324.
Murota, K & Terao, J 2003 Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 417 12–17.
Nemeth, K, Plumb, GW, Berrin, JG, Juge, N, Jacob, R, Naim, HY, Williamson, G, Swallow, DM & Kroon, PA 2003 Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flaronoid glycosides in humans. Eur J Nutr 42 29–42.
O'Prey, J, Brown, J, Fleming, J & Harrison, PR 2003 Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells. Biochem Pharmacol 66 2075–2088.
Ramachandra, R, Shetty, AK & Salimath, PV 2005 Quercetin alleviates activities of intestinal and renal disaccharidases in streptozotocininduced diabetic rats. Mol Nutr Food Res 49 355–360.
Sang, KN & Sung, IK 2003 Egg sphingomyelin lowers the lymphatic absorption of cholesterol and a-tocopherol in rats. J Nutr 133 3571–3576.
Schmelz, EM, Dillehay, DL, Webb, SK, Reiter, A, Adams, J & Merrill, AH Jr 1996 Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1, 2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res 56 4936–4941.
Schmelz, EM, Sullards, MC, Dillehay, DL & Merrill, AH 2000 Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. J Nutr 130 522–527.
Schmelz, EM, Roberts, PC, Kustin, EM, Jr Lemonnier, LA, Sullards, MC, Dillehay, DL & Merrill, AH Jr (2001) Modulation of intracellular bcatenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids Cancer Res. 61 6723–6729.
Shiraga, T, Miyamoto, K, Tanaka, H, Yamamoto, H, Taketani, Y, Morita, K, Tamai, I, Tsuji, A & Takeda, E 1999 Cellular and molecular mechanisms of dietary regulation on rat intestinal H+/peptide transporter PepT1. Gastroenterology 116 354–362.
Shirazi-Beechey, SP, Davies, AG, Tebbutt, K, Dyer, J, Ellis, A, Taylor, CJ, Fairclough, P & Beechey, RB 1990 Preparation and properties of brush border membrane vesicles from human small intestine. Gastroenterology 98 676–685.
Strobel, P, Allard, C, Pérez-Acle, T, Calderon, R, Aldunate, R & Leighton, F 2005 Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated adipocytes. Biochem J 386 471–478.
Uezato, T & Fujita, M 1983 Developmental transition of alkaline phosphatase from suckling to adult type in rat small intestine: molecular species and effect of injected cortisone and thyroxine. J Biochem 94 1483–1488.
Vesper, H, Schmelz, EM, Nikolova-Karakashian, MN, Dillehay, DL, Lynch, DV & Merrill, AH Jr 1999 Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 129 1239–1250.
Wenzel, U, Kuntz, S & Daniel, H 2001 Flavonoids with epidermal growth factor-receptor tyrosine kinase inhibitory activity stimulates PEPT1-mediated cefixime uptake into human epithelial cells. J Pharmacol Exp Ther 299 351–357.